Krystal Biotech (KRYS) Other Working Capital Changes (2016 - 2026)

Krystal Biotech has disclosed Other Working Capital Changes across 11 years of filings, most recently posting $136000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $136000.0, down 96.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 million (down 123.53% YoY), and the FY2025 annual result was $2.3 million, up 249.69% from the prior year.
• Other Working Capital Changes came in at $136000.0 for Q1 2026 at Krystal Biotech, down from $562000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $3.4 million in Q1 2025 to a low of -$2.1 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is $327000.0 (2024), against an average of $311470.6.
• Across the five-year window, Other Working Capital Changes sank 23900.0% in 2024 and soared 1542.44% in 2025, its largest moves.
• Krystal Biotech's Other Working Capital Changes stood at $839000.0 in 2022, then surged by 36.83% to $1.1 million in 2023, then slumped by 109.49% to -$109000.0 in 2024, then soared by 615.6% to $562000.0 in 2025, then plunged by 75.8% to $136000.0 in 2026.
• The last three Other Working Capital Changes figures came in at $136000.0 (Q1 2026), $562000.0 (Q4 2025), and $350000.0 (Q3 2025), per Business Quant data.